Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Non-Therapeutic Biomolecules Market Heading Into 2029?
The marketplace for non-therapeutic biomolecules has experienced rapid expansion in the past few years. The market value will increase from $30.76 billion in 2024 to $33.92 billion in 2025, projecting a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period is due to factors such as heightened investment in research and development (R&D), expanding applicability in research and diagnostic fields, increasing awareness and adoption, strategic collaborations and agreements, and supportive regulatory frameworks.
The market size of non-therapeutic biomolecules is projected to swiftly expand in the near future, swelling to “$51.03 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The anticipated expansion during this forecasted timeframe is due to diverse factors such as the evolution of new market opportunities, the progressive advancements in data analytics and integration, an intensified focus on precision medicine, heightened investments in personalized healthcare, and broader application areas. Among the major trends expected to appear during this forecast period are technological progression, mutual strategic partnerships, surging applications in the agriculture sector, a growing influence in industrial procedures, along with customization and personalization.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
Which Factors Are Pushing The Non-Therapeutic Biomolecules Market Forward?
The non-therapeutic biomolecules market is anticipated to grow due to the rapidly escalating volume of research and laboratory tests. Laboratory testing involves medical procedures that test samples of blood, urine, or other substances in the body to diagnose diseases, monitor their progress, and formulate a treatment plan. On the other hand, research tasks create new knowledge or apply existing knowledge creatively to develop new concepts, theories, and understanding. In laboratory testing, non-therapeutic biomolecules are employed to detect the presence or level of biomarker molecules indicative of disease, thus increasing the test’s sensitivity and specificity. For example, the National Health Service (NHS), a UK-based hospital, and healthcare provider, reported in July 2024 that diagnostic activity surpassed pre-pandemic levels in 2023, recording a 21% surge in tests conducted in May 2024 compared to the same month the previous year. This burgeoning volume of research and laboratory testing is thus fueling the expansion of the non-therapeutic biomolecules market.
Which Segment Held The Largest Share In The Non-Therapeutic Biomolecules Market In 2025?
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)
Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Which Emerging Trends And Strategic Shifts Are Shaping The Non-Therapeutic Biomolecules Market?
A notable trend occurring in the non-therapeutic biomolecules market is product innovation. Dominant entities in this field are dedicating resources towards research and development in an endeavor to maintain their market standing. In January 2022, an example of this was illustrated when BASF SE, a multinational chemical company based in Germany, entered into a strategic partnership with Caregen, a biomimetic peptide research and development firm based in Korea. Together, they launched the Peptovitae series, utilizing liposome encapsulated technology. This series has been added to the company’s dermo-cosmetic portfolio, providing a range of innovative and unique solutions for various skin concerns. Liposomal encapsulation involves using fats to selectively deliver essential vitamins or medications within the body while minimizing impact on unrelated sections of the body. The Peptovitae series surpasses the traditional peptide applications, addressing problems including signs of aging, enhancing skin radiance, soothing dry and itchy skin, and skin hydration.
Which Organizations Are Driving Progress In The Non-Therapeutic Biomolecules Industry?
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Which Region Is Expected To Experience The Highest Growth In The Non-Therapeutic Biomolecules Industry?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model